Burjeel Holdings Becomes First Healthcare Institution in the UAE to Earn NIHS Accreditation for Hematology-Oncology Fellowship Program 

Burjeel Holdings Becomes First Healthcare Institution in the UAE to Earn NIHS Accreditation for Hematology-Oncology Fellowship Program 

The Orthopedic Residency and Hematology-Oncology Fellowship programs will equip physicians with the expertise needed to meet global healthcare standards

Abu Dhabi, February 15, 2025: Burjeel Holdings, a leading super-specialty healthcare provider in the MENA region, has achieved a significant milestone in healthcare education by receiving accreditation from the National Institute for Health Specialties (NIHS), a prestigious accreditation program in the UAE. The two specialized medical training programs—Orthopedic Residency and Hematology-Oncology Fellowship—have secured this accreditation. The Hematology-Oncology Fellowship marks a milestone for Burjeel Holdings as the first healthcare provider in the UAE to achieve this recognition, while the accreditation for the Orthopedic Residency sets a precedent in Abu Dhabi’s private healthcare sector.

The accreditation was officially conferred by Dr. Mohammed Al Houqani, Secretary General of NIHS during a ceremony attended by Dr. Shamsheer Vayalil, Founder and Chairman of Burjeel Holdings, H.E. Dr. Rashed Alsuwaidi, the Acting Director General of Healthcare Regulatory at Department of Health – Abu Dhabi, Mr. John Sunil, Group CEO of Burjeel Holdings, and Mr. Safeer Ahamed, Group Co-CEO of Burjeel Holdings.

Dr. Mohammed Al Houqani praised Burjeel Holdings’ role in advancing medical education, highlighting its significant contributions to training the healthcare workforce and equipping them with the highest global standards. He emphasized the Group’s efforts in creating an ideal training environment based on best medical practices, which will strengthen the healthcare sector with specialized and qualified physicians capable of delivering high-quality medical services for healthcare challenges.

Speaking about this achievement, Dr. Tahani Al Qadiri, Group Director of Emiratization and Academics at Burjeel Holdings, said that this accreditation is a testament to Burjeel’s commitment to raising the next generation of specialized healthcare professionals in the region. “This milestone not only strengthens our position as a leader in private-sector medical education but also contributes significantly to Abu Dhabi’s healthcare ecosystem by nurturing highly skilled specialists,” she added.

These specialized programs will provide rigorous, hands-on training for medical residents and fellows, equipping them with the expertise required to meet global healthcare standards. The Orthopedic Residency Program will prepare aspiring trainees with comprehensive clinical experience, while the Hematology-Oncology Fellowship Program will cultivate highly specialized expertise in cancer care.

According to Prof. Humaid Al Shamsi, CEO of Burjeel Cancer Institute, the initiative will contribute to better patient outcomes. “By establishing the first accredited Hematology-Oncology Fellowship Program in the private sector in the country, we are creating a structured pathway for developing highly skilled oncologists who will play a crucial role in enhancing cancer care in the region,” he said.

Dr. Mohamed Muath ADI, Consultant Orthopedic Surgeon at Burjeel Medical City (BMC) and Program Director of the Orthopedic Residency Program, said that this milestone will enhance the quality of orthopedic education and training in the region, further elevating the standard of orthopedic care in the UAE.

This accreditation, aligning with the UAE’s strategic vision to advance the healthcare sector, reflects Burjeel’s commitment to advancing medical education, and positioning Abu Dhabi as a hub for world-class medical training.